Super DNA/RNA Extraction Solution Program within Your Reach

Company news
2021-09-22

The fast spread of COVID-19 variants requires fast, high throughput, efficient and flexible testing solution

 

According to the latest data, COVID-19 variants caused a dramatic increment in confirmed cases. Some variants seem to spread more easily and quickly than others. Delta and Mu are the most noteworthy variants recently. WHO categorizes Delta variants as "variants of concern (VOC)", Mu Variants as "Variants of Interest (VOI)". But it should be noted that the classification is not permanent and depends on the influence of variants.

Under the urgent and sudden situation, quick and high throughput requirements is also been raised by some medical institutes, especially ones that need large sample size screening.

Nucleic Acid Extraction plays an important role in the PCR testing procedure

Bioperfectus Nucleic Acid Extraction Systems apply the magnetic bead method. The magnetic bead method nucleic acid extraction kit uses a unique separation of magnetic beads and a buffer system to separate and purify high-quality genomic DNA from the sample. Special coated magnetic beads have a strong affinity for the target DNA under certain conditions. , And when the conditions change, the magnetic beads release the adsorbed DNA, which can achieve the purpose of rapid separation and purification of DNA. The whole process does not involve toxic reagents, it is safe, convenient, and the extracted DNA is of high purity. 

 

Nucleic acid extraction is the key step before PCR operation, and after PCR amplification, we will get a final diagnostic result. For the efficiency and precision of the detection, the nucleic acids extracted in the beginning step should be with high quality within a short period. The technique for fast, simple and efficient nucleic acid extraction is then essential for this procedure.

“COVID-19 Express” Program provides fast, efficient solutions for COVID-19 samples.

To confront the fast-growing COVID-19 cases, we Bioperfectus are glad to release a rapid Nucleic acid extraction program.

Extraction Protocol Compatible Bioperfectus Extraction Kit
(Catalog Number)
Sample Type
"COVID-19 Express" Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) (SDKF60101, SDKF60101D)

Pharyngeal swabs,

nasal swabs

Based on the new program, we also delightfully recommend several nucleic acid extraction solutions to meet the demand of a large sample size.

Sample size 1000-5000 T/day 5000-8000 T/day
Nucleic acid extraction Solutions

SSNP-3000A x 1

            or

SSNP-2000B x 2

SSNP-9600A x 1

           or

SSNP-3000A x 2

       or

SSNP-2000B x 3

*Sample size is calculated based on is 22h/day working time, 2h/day for decontamination.

 

SSNP series extractors - SSNP 2000B/3000A/9600A with Nucleic Acid Extraction Rapid Kit (SDKF60101/SDKF60101D) will accomplish nucleic acid extraction in less than 15 minutes for 1-96 COVID-19 samples, which will accelerate the precious time before PCR amplification. With the “COVID-19 Express” program, laboratories will have the chance to get a faster, easier nucleic acid extraction solution, which also provides high-quality nucleic acid for the followed downstream applications.

 

Upcoming New Extraction Solutions Preview    

Soon we will launch an “Automated Nucleic Acid Extraction Workstation”--SAW-96, which will realize fully automatic sampling and nucleic acid extraction function in a closed system, and get ready for PCR procedure.

SMPE series extractor provides flexible solutions for COVID-19 samples

SMPE series extractor - SMPE 960

has three individual detection modules, that will help the operators to detect the samples with different arrival times, which provide a flexible choice for urgent, special, or retested samples. If laboratories need to detect samples from time to time, SMPE 960 can offer a more flexible solution to meet the demand.

 

If you want to know more about our nucleic acid extraction solution, please feel free to contact us via info@bioperfectus.com , media cooperation and conference information, please contact with marketing_global@bioperfectus.com

 

References

  • WHO Coronavirus (COVID-19) Dashboard
  • SARS-CoV-2 variants of public health interest: 22 September 2021
MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14